A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Tumors positive for estrogen receptors are the most common subtype of breast cancer. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free ...
NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...
Hosted on MSN
Pfizer Stock Climbs Pre-Market On Bladder Cancer Trial Success: Retail Digests Data Ahead Of Q1 Print
Shares of Pfizer Inc (PFE) rose 0.6% in early premarket trading on Monday, tracking a three-week high, after the drugmaker reported positive late-stage trial results for its experimental bladder ...
NEW YORK - Pfizer on Wednesday shared data about a third dose of its COVID-19 vaccine that suggests it "strongly" boosts protection against the more contagious delta variant of the coronavirus, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback